New Key Statistics Module, Z-Score and F-Score
XTER:VIH1 Key Ratios
Market Cap € M | 229.40 |
Enterprise Value € M | 1,053.53 |
P/E(ttm) | 1.74 |
PE Ratio without NRI | 1.74 |
Forward PE Ratio | 6.14 |
Price/Book | 0.27 |
Price/Sales | 2.09 |
Price/Free Cash Flow | 3.03 |
Price/Owner Earnings | 1.24 |
Payout Ratio % | -- |
Revenue (TTM) € M | 108.00 |
EPS (TTM) € | 3.92 |
Beneish M-Score | 34.3 |
10-y EBITDA Growth Rate % | 7.30 |
5-y EBITDA Growth Rate % | 11.10 |
y-y EBITDA Growth Rate % | 70.90 |
EV-to-EBIT | 5.78 |
EV-to-EBITDA | 4.99 |
PEG | 0.16 |
Shares Outstanding M | 33.05 |
Net Margin (%) | 119.99 |
Operating Margin % | 50.16 |
Pre-tax Margin (%) | 140.45 |
Quick Ratio | 7.86 |
Current Ratio | 7.86 |
ROA % (ttm) | 7.36 |
ROE % (ttm) | 16.63 |
ROIC % (ttm) | 2.97 |
Dividend Yield % | 0.57 |
Altman Z-Score | 1.14 |
XTER:VIH1 Number of Guru Trades
XTER:VIH1 Volume of Guru Trades
Gurus Latest Trades with XTER:VIH1
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XTER:VIH1 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data